TempraMed Technologies Ltd. develops patent-protected medical device technology aimed at various medical and consumer applications. While the company boasts a strong gross margin of 54.9%, it faces significant concerns with negative EBITDA and net margins, indicating operational inefficiencies. Additionally, a current ratio of 0.25 and quick ratio of 0.10 suggest liquidity challenges. The high gross margin juxtaposed with low valuation raises questions about the company's ability to convert revenue into profit effectively. Overall, while there are strengths in its technology, financial health remains a critical concern.
Loading financial metrics...
Company has $28K in cash but burned $1.2M last quarter. At this burn rate, only 0.0 quarters of runway remain without additional financing.
Gross profit margin declined from 64.5% to 43.9% year-over-year, suggesting pricing pressure or rising input costs are squeezing profitability.
Company posted a loss of $-20.4M over the last year, representing 1047.9% of revenue.
Debt of $1.6M is 56.8x the company's cash position of $28K.
Operating cash flow has been negative for 3 consecutive quarters, burning $4.6M over the last year.
No significant opportunities identified
Based on current financial metrics
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Medical Devices companies of a similar size
Based on 2026-Q2 (June 30, 2026)